ArticleBMC women's health2025
Assessing Uterine Fibroid Symptoms and Health-related Quality of Life among women at Korle Bu Teaching Hospital, Ghana: an analytical cross-sectional study using the UFS-QoL questionnaire.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUterine fibroids are highly prevalent and constitute significant health and social concerns, particularly among black-African women of reproductive age. However, beyond the clinical burden, there is limited data on the extent to which fibroid-related symptoms impact patients' Quality of Life (QoL) in sub-Saharan Africa. This study assessed the Symptoms-Related QoL of women with uterine fibroids at Korle Bu Teaching Hospital, Ghana. This work appears to be the first study in our setting to investigate the subject.
methodWe conducted an analytical cross-sectional study utilizing the validated Uterine Fibroid Symptom and Health-Related Quality of Life (UFS-QoL) questionnaire to collect data among women undergoing fibroid treatment at the largest referral hospital in Ghana between January and April 2023. Women 18years and above, diagnosed with uterine fibroids were included using a systematic random sampling, while those with other major concurrent gynaecological disorders such as endometriosis, ovarian cysts, cancers were excluded. Analysis focused on identifying the prevalent symptoms and complications associated with uterine fibroids and their impact on affected women's QoL. Data were analyzed using SPSS Statistical Software version 25. Descriptive statistics were used to summarize participants' sociodemographic and clinical characteristics. Associations between sociodemographic variables and UFS-QoL scores were assessed using the Student t-test, Pearson correlation, and linear regression. Statistical significance was set at a p-value of less than 0.05.
resultsThe mean symptom severity and QoL subscale scores were: Symptom Severity Score - 34.6 ± 13.6, Concern - 63.2 ± 18.3, Activities - 62.9 ± 17.4, Energy/Mood - 61.5 ± 15.5, Control - 58.7 ± 17.9, Self-conscious - 58.3 ± 20.1 and Sexual function score - 61.4 ± 23.5. Moderate-to-severe uterine fibroid-related symptoms were reported among 35% of the 163 participants; the most-worrisome symptom was heavy menstrual bleeding. Significantly, 83.4% of participants reported a moderate-to-severe impact of uterine fibroids on their QoL, with higher symptom severity correlating with lower health-related quality of life (HR-QoL) scores. There was a significant correlation between HR-QoL subscale scores and the overall HR-QoL score. There was no significant association between participants' sociodemographic characteristics and their symptom severity or HR-QoL scores.
conclusionThere was moderate to severe impairment in the quality of life of women with uterine fibroids. QoL impairment significantly correlated with the severity of the symptoms of fibroids. Clinical care should focus some attention on addressing QoL challenges due to uterine fibroids for improved well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.